diPaRIS: Dynamic and Interpretable Protein‐RNA Interactions Prediction With U‐Shaped Network and Novel Structure Encoding
Advanced Science · 2025
DOI: 10.1002/advs.202506314 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Lishen Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Computer Science and Engineering, Central South University, Changsha, 410083, China. Hauptthemen laut MEDLINE: RNA, RNA-Binding Proteins, Computational Biology, Deep Learning. Die Arbeit nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: STI2030-Major Projects, National Natural Science Foundation of China, Project of Xiangjiang Laboratory.
Abstract (Originalsprache)
Protein‐RNA interactions play a critical role in various biological processes and disease development. Proteins interact with RNAs through dynamic binding sites that exhibit specific structural patterns under various cellular conditions. While current computational methods take RNA structures in vivo into account, they fall short in capturing the structure contextual association of nucleotides, limiting predictive accuracy. Here, diPaRIS, a deep learning method, is proposed to predict dynamic protein‐RNA interactions with improved accuracy and enhanced interpretability by integrating RNA structures in vivo. diPaRIS introduces a novel encoding scheme for SHAPE‐seq to encode nucleotide correlations, providing a more comprehensive representation of RNA structures. Leveraging a U‐shaped network architecture, diPaRIS not only improves prediction performance but also enables interpretable analysis by learning sequence binding motifs and generating attribution maps. Benchmarking diPaRIS across 44 datasets shows its superiority over existing methods. The model consistently achieves the highest accuracy, AUC, AUPR, and F1‐score across all datasets. Additionally, diPaRIS excels in cross‐cell line predictions, consistently outperforming the second‐best method across all datasets. Predictions by diPaRIS reflect the conservation of protein‐RNA binding and facilitate further functional interpretation of genetic variants in complex diseases. The findings highlight that diPaRIS effectively predicts protein‐RNA interactions and interprets potential gene‐disease associations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Computer Science and Engineering, Central South University, Changsha, 410083, China.
- Xiangjiang Laboratory, Changsha, 410205, China.
- Hunan Provincial Key Lab on Bioinformatics, Central South University, Changsha, 410083, China.
- School of Computer Science, Xiangtan University, Xiangtan, 411105, China.
- Center for Medical Genetics & Hunan Key Laboratory of Medical Genetics, School of Life Sciences, Central South University, Changsha, 410083, China.
- Xinjiang Engineering Research Center of Big Data and Intelligent Software, School of Software, Xinjiang University, Urumqi, 830091, China.
ORCID-Profile: Jianxin Wang
Förderung
- STI2030-Major Projects
- National Natural Science Foundation of China
- Project of Xiangjiang Laboratory
- Fundamental Research Funds for the Central Universities of Central South University
Zitieren
APA
Zhang, L., Lu, C., Peng, X., Guo, F., Li, H., & Wang, J. (2025). diPaRIS: Dynamic and Interpretable Protein‐RNA Interactions Prediction With U‐Shaped Network and Novel Structure Encoding. Advanced Science. https://doi.org/10.1002/advs.202506314
Vancouver
Zhang L, Lu C, Peng X, Guo F, Li H, Wang J. diPaRIS: Dynamic and Interpretable Protein‐RNA Interactions Prediction With U‐Shaped Network and Novel Structure Encoding. Advanced Science. 2025. doi:10.1002/advs.202506314
BibTeX
@article{Zhang2025,
author = {Zhang, Lishen and Lu, Chengqian and Peng, Xiaoqing and Guo, Fei and Li, Hongdong and Wang, Jianxin},
title = {diPaRIS: Dynamic and Interpretable Protein‐RNA Interactions Prediction With U‐Shaped Network and Novel Structure Encoding},
journal = {Advanced Science},
year = {2025},
doi = {10.1002/advs.202506314}
}
EUVIMED